Evaluation of Fiasp ® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy

Condition:   Diabetes Mellitus, Type 1 Interventions:   Drug: Fiasp;   Drug: Novolog Sponsors:   Stanford University;   Medtronic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials